Clove (Syzygium aromaticum L.), a potential chemopreventive agent for lung cancer

Carcinogenesis

Volumn 27, Issue 8, 2006, Pages 1645-1654

  Banerjee, Sarmistha ^a   Panda, Chinmay Kr ^a   Das, Sukta ^a  

^a Chittarajan National Cancer Institute   (India)

Author keywords

[No Author keywords available]

Indexed keywords

BENZO[A]PYRENE; CASPASE 3; CLOVE EXTRACT; CYCLOOXYGENASE 2; GROWTH PROMOTOR; MYC PROTEIN; PLANT EXTRACT; PROTEIN BAX; PROTEIN BCL 2; PROTEIN P53; RAS PROTEIN; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTINEOPLASTIC ACTIVITY; APOPTOSIS; AQUEOUS SOLUTION; ARTICLE; CANCER CELL; CANCER STAGING; CARCINOMA IN SITU; CELL COUNT; CELL PROLIFERATION; CLOVE; CONTROLLED STUDY; DOWN REGULATION; DRUG DOSE REGIMEN; DRUG EFFICACY; DRUG INFUSION; DRUG MECHANISM; ENZYME ACTIVATION; GENETIC CODE; HISTOPATHOLOGY; HYPERPLASIA; LUNG CANCER; LUNG CARCINOGENESIS; LUNG DYSPLASIA; MOUSE; NEWBORN; NONHUMAN; ONCOGENE H RAS; PRECANCER; PRIORITY JOURNAL; PROTEIN EXPRESSION; UPREGULATION; WESTERN BLOTTING;

ANIMALS; ANIMALS, NEWBORN; APOPTOSIS; BCL-2-ASSOCIATED X PROTEIN; BENZO(A)PYRENE; CARCINOMA IN SITU; CELL PROLIFERATION; CHEMOPREVENTION; CYCLOOXYGENASE 2; EUGENIA; FEMALE; GENES, RAS; HYPERPLASIA; LUNG NEOPLASMS; MICE; PLANT EXTRACTS; PROTO-ONCOGENE PROTEINS C-BCL-2; TUMOR SUPPRESSOR PROTEIN P53;

EID: 33747873525     PISSN: 01433334     EISSN: 14602180     Source Type: Journal    
DOI: 10.1093/carcin/bgi372     Document Type: Article

References (59)

1. Doll,R. (1992) The lessons of life: Keynote address to the nutrition and cancer conference. Cancer Res., 52, 2024s-2029s.
2. Wattenberg,L.W. (1992) Inhibition of carcinogenesis by minor dietary constituents. Cancer Res., 52, 2085s-2091s.
3. Das,S. (2004a) Food phytochemicals and cancer chemoprevention. Sci. Cult., 70, 131-135.
4. Unnikrishnan,M.C. and Kuttan,R. (1990) Tumour reducing and anticarcinogenic activity of selected spices. Cancer Lett., 51, 85-89.
5. Das,S. (2004b) Anticancer potential of flavouring agents and their active principles- garlic, saffron, clove. Int. J. Cancer Prev., 1, 89-97.
6. Das,I., Chakrabarty,R.N. and Das,S. (2004) Saffron can prevent chemically induced skin carcinogenesis in Swiss albino mice. Asian Pacific J. Cancer Prev., 5, 70-76.
7. Sengupta,A., Ghosh,S. and Bhattacharjee,S. (2005) Dietary cardamom inhibits the formation of azoxymethane induced aberrant crypt foci in mice and reduces cox-2 and iNos expression in colon. Asian Pacific J. Cancer Prev., 6, 118-122.
8. Zheng,G.Q., Kenney,P.M. and Lam,L.K. (1992) Sesquiterpenes from clove (Eugenia caryophyllata) as potential anticarcinogenic agents. J. Nat. Prod., 55, 999-1003.
9. Srivastava,K.C. and Malhotra,N. (1991) Acetyl eugenol, a component of oil of cloves (Sygium aromaticum L) inhibits aggregation and alters arachidonic acid metabolism in human blood platelets. Prostaglandins Leukot. Essent. Fatty Acids, 42, 73-81.
10. Naik,P., Karrim,J. and Hanahan,D. (1996) The rise and fall of apoptosis during multistage tumorigenesis: Down-modulation contributes to tumor progression from angiogenic progenitors. Genes Dev., 10, 2105-2116.
11. Hong,M.Y., Chang,W.C., Chapkin,R.S. and Lupton,J.R. (1997) Relationship among colonocyte proliferation, differentiation and apoptosis as a function of diet and carcinogen. Nutr. Cancer, 28, 20-29.
12. Das,T., Sa,G., Sinha,P. and Ray,P.K. (1999) Induction of cell proliferation and apoptosis: Dependence on the dose of the inducer. Biochem. Biophys. Res. Commun., 260, 105-110.
13. Basu,A. and Haldar,S. (1998) The relationship between BcI2, Bax and p53:cOnsequences for cell cycle progression and cell death. Mol. Hum. Reprod., 4, 1099-1109.
14. Levin,A.J. (1997) p53, the cellular gatekeeper for growth and division. Cell, 88, 323-331.
15. Miyashita,T. and Reed,J.C. (1995) Tumor suppressor p53 is a direct transcriptional activator of the human bax gene. Cell, 80, 293-299.
16. Bickers,D.R. and Athur,M. (2000) Novel approaches to chemoprevention of skin cancer. J. Dermatol., 27, 691-695.
17. Shibata,M.A., Maroulakour,I.G., Jorcyk,C.L., Gold,L.G., Ward,J.M. and Green,J.E. (1996) p53-independent apoptosis during mammary tumor progression in C3(1)/SV40 large T antigen transgenic mice: Suppression of apoptosis during the transition from preneoplasia to carcinoma. Cancer Res., 56, 2998-3003.
18. Miyashita,T., Krajewski,S., Krajewska,M., Wang,H.G., Lin,H.K., Liebermann,D.A., Hoffman,B. and Reed,J.C. (1994) Tumor suppressor p53 is a regulator of bcl-2 and bax gene expression in vitro and in vivo. Oncogene, 9, 1799-1805.
19. Tsujii,M. and DuBois,R.N. (1995) Alterations in cellular adhesion and apoptosis in epithelial cells overexpressing prostaglandin endoperoxide synthase 2. Cell, 83, 493-501.
20. DuBois,R.N., Shao,J., Tsujii,M., Sheng,H. and Beauchamp,R.D. (1996) G1 delay in cells overexpressing prostaglandin endoperoxide synthase-2. Cancer Res., 56, 733-737.
21. Askew,D.S., Ashmun,R.A., Simmons,B.C. and Cleveland,J.L. (1991) Constitutive c-myc expression in IL-3-dependent myeloid cell line suppresses cycle arrest and accelerates apoptosis. Oncogene, 6, 1915-1922.
22. Evan,G.I., Wyllie,A.H., Gilbert,C.S., Littlewood,T.D., Land,H., Brooks,M., Waters,C.M., Penn,L.Z. and Hancock,D.C. (1992) Induction of apoptosis in fibroblasts by c-myc protein. Cell, 69, 119-128.
23. Leone,G., DeGregori,J., Sears,R., Jakoi,L. and Nevins,J.R. (1997) Myc and Ras collaborate in inducing accumulation of active cyclin E/Cdk2 and E2F. Nature, 387, 422-426.
24. Jemal,A., Murray,T., Ward,E., Samuels,A., Tiwari,R.C., Ghafoor,A., Feuer,E.J. and Thun,M.J. (2005) Cancer Statistics, 2005. CA Cancer J. Clin., 55, 10-30.
25. Sethi,T. (2002) Lung cancer: Introduction. Thorax, 57, 992-993.
26. Hecht,S.S., Carmella,S.G., Murphy,S.E., Foiles,P.G. and Chung,F.L. (1993) Carcinogen biomarkers related to smoking and upper aerodigestive tract cancer. J. Cell Biochem., 17F, 27-35.
27. King,H.W., Osborne,M.R. and Brookes,P. (1979) The in vitro and in vivo reaction at the N7-position of guanine of the ultimate carcinogen derived from benzo(a)pyrene. Chem. Biol. Interact., 24, 345-353.
28. Davidson,L.A., Brown,R.E., Chang,W.C., Morris,J.S., Wang,N., Carroll,R.J., Turner,N.D., Lupton,J.R. and Chapkin,R.S. (2000) Morphodensitometric analysis of protein kinase expression C beta(II) expression in rat colon: Modulation by diet and relation to in situ cell proliferation and apoptosis. Carcinogenesis, 21, 1513-1519.
29. Caderni,G., De Filippo,C., Luceri,C., Salvadori,M., Giannini,A., Biggeri,A., Remy,S., Cheynier,V. and Dolara,P. (2000) Effects of black tea, green tea and wine extracts on intestinal carcinogenesis induced by azoxymethane in F344 rats. Carcinogenesis, 21, 1965-1969.
30. Lowry,O.H., Rosenbrough,N.J., Farr,A.L. and Randall,R.J. (1951) Protein measurement with the Folin phenol reagent. J. Biol. Chem., 193, 265-276.
31. Banerjee,S. and Das,S. (2004) Chemopreventive efficacy of black tea on benzo(a)pyrene induced lung carcinogenesis. Int. J. Cancer Prev., 1, 129-136.
32. He,Z., Ma,W.Y., Hashimoto,T., Bode,A.M., Yang,C.S. and Dong,Z. (2003) Induction of apoptosis by caffeine is mediated by the p53, Bax, and caspase 3 pathways. Cancer Res., 63, 4396-4401.
33. Wardlaw,S.A., March,T.H. and Belinsky,S.A. (2000) Cyclooxygenase-2 expression is abundant in alveolar type II cells in lung cancer-sensitive mouse strains and in premalignant lesions. Carcinogenesis, 21, 1371-1377.
34. Pelengaris,S., Rudolph,B. and Littlewood,T. (2000) Action of Myc in vivo - proliferation and apoptosis. Curr. Opin. Genet. Dev., 10, 100-105.
35. Obaya,A.J., Mateyak,M.K. and Sedivy,J.M. (1999) Mysterious liaisons: The relationship between c-Myc and the cell cycle. Oncogene, 18, 2934-2941.
36. Zachos,G. and Spandidos,D.A. (1997) Expression of ras proto-oncogenes: regulation and implications in the development of human tumors. Crit. Rev. Oncol. Hematol., 26, 65-75.
37. Weinstein,I.B. (1991) Cancer prevention: Recent progress and future opportunities. Cancer Res., 51, 5080s-5085s.
38. DiGiovanni,J. (1992) Multistage carcinogenesis in mouse skin. Pharmacol. Ther., 54, 63-128.
39. AACR Chemoprevention Working Group (1999), Prevention of cancer in the next millennium: Report of the chemoprevention working group to the American Association for Cancer Research. Cancer Res., 59, 4743-4758.
40. Banerjee,S. and Das,S. (2005) Anticarcinogenic effect of aqueous infusion of clove on skin carcinogenesis. Asian Pacific J. Cancer Prev., 6, 304-308.
41. Bedi,A., Pasricha,P.J., Akhtar,A.J., Barber,J.P., Bedi,G.C., Giardiello,F.M., Zehnbauer,B.A., Hamilton,S.R. and Jones,R.J. (1995) Inhibition of apoptosis during development of colorectal cancer. Cancer Res., 55, 1811-1816.
42. 1 cell cycle arrest and apoptosis in prostate cancer cells. Oncogene, 20, 2927-2936.
43. 2 arrest instead of mitotic arrest: Molecular determinants of paclitaxel-induced cytotoxicity. Oncogene, 20, 3806-3813.
44. Oltvai,Z.N., Milliman,C.L. and Korsmeyer,S.J. (1993) Bcl-2 heterodimerizes in vivo with a conserved homolog, Bax, that accelerates programmed cell death. Cell, 74, 609-619.
45. Marzo,I., Brenner,C., Zamzami,N. et al. (1998) Bax and adenine nucleotide translocator cooperate in the mitochondrial control of apoptosis. Science, 281, 2027-2031.
46. Hoshi,T., Sasano,H., Kato,K., Yabuki,N., Ohara,S., Konno,R., Asaki,S., Toyota,T., Tateno,H. and Nagura,H. (1998) Immunohistochemistry of caspase-3/CPP32 in human stomach and its correlation with cell proliferation and apoptosis. Anticancer Res., 18, 4347-4353.
47. Wang,X. (2001) The expanding role of mitochondria in apoptosis. Genes Dev., 15, 2922-2933.
48. Gupta,S. (2003) Molecular signaling in death receptor and mitochondrial pathways of apoptosis (review). Int. J. Oncol., 22, 15-20.
49. Bennett,A. (1986) The production of prostonoids in human cancers and their implications for tumor progression. Prog. Lipid Res., 25, 539-542.
50. Amati,B., Alevizopoulos,K. and Vlach,J. (1998) Myc and the cell cycle. Front Biosci., 3, D250-D268.
51. Dang,C.V. (1999) C-MYC target genes involved in cell growth, apoptosis, and metabolism. Mol. Cell. Biol., 19, 1-11.
52. Eilers,M. (1999) Control of cell proliferation by Myc family genes. Mol. Cells., 9, 1-6.
53. Amati,B. (2001) Integrating Myc and TGF-beta signaling in cell cycle control. Nat. Cell Biol., 3, E112-E113.
54. Rayter,S.I., Iwata,K.K., Michitsch,R.W., Sorvillo,J.M., Valenzuela,D.M. and Foulkes,J.G. (1989) Biochemical functions of oncogenes. In: Glover,D.M., Hames,B.D. (eds.), Oncogene. IRL Press, Oxford, pp. 113-189.
55. Maculuso,M., Russo,G., Cinti,C., Bazan,V., Gebbia,N. and Russo,A. (2002) Ras family genes: An interesting link between cell cycle and cancer. J. Cell Physiol., 192, 125-130.
56. Barbacid,M. (1987) Ras gene. Annu. Rev. Biochem., 56, 779-827.
57. Bos,J.L. (1989) Ras oncogene in human cancer: A review. Cancer Res., 49, 4689-4692.
58. Rinker-Schaeffer,C.W., Graff,J.R., De Benedetti,A., Zimmer,S.G. and Rhoads,R.E. (1993) Decreasing the level of translation initiation factor 4E with antisense RNA causes reversal of ras-mediated transformation and tumorigenesis of cloned rat embryo fibroblasts. Int. J. Cancer, 55, 841-847.
59. Prendergast,G.C., Davide,J.P., Lebowitz,P.F., Wechsler-Reya,R. and Kohl,N.E. (1996) Resistance of a variant ras-transformed cell line to phenotypic reversion by farnesyl transferase inhibitors. Cancer Res., 56, 2626-2632.